RECENT NEWS  4 hrs ago  Comment 
Multibillion-dollar consolidation of global pharmaceutical sector continues with another blockbuster The multibillion-dollar consolidation of the global pharmaceutical sector has seen another blockbuster deal after Switzerland's Roche agreed to...
Yahoo  7 hrs ago  Comment 
LONDON/ZURICH (Reuters) - Roche Holding AG has agreed to buy U.S. The Swiss drugmaker said on Sunday it would pay $74.00 a share through a tender offer for InterMune, representing a premium of 38 percent to the closing price on Aug. 22. The...
Motley Fool  10 hrs ago  Comment 
Biotech investing might appear easy considering some of the big gains we've witnessed in recent years, but these three common mistakes make it very difficult for the average biotech investor to make money.
SeekingAlpha  Aug 23  Comment 
By Stephen Simpson, CFA: The last year hasn't actually been all that bad for biotech, as the S&P Biotech ETF (NYSEARCA:XBI) has outperformed the S&P 500 by about six or seven points. Whether or not the XBI is a great benchmark for the biotech...
Commodity Online  Aug 23  Comment 
Considering that agriculture has a share of about 18 per cent in India and rsquo;s gross domestic product (GDP) and employs over half of country and rsquo;s population, the sector holds grave significance in view of its role in ensuring food...  Aug 22  Comment 
BOSTON (TheStreet) -- Aalate summer Biotech Stock Mailbag. Sean L. writes: Big fan and follower of all things biotech. I came across the Feuerstein-RatainaRule. I don't doubt the validity or consistency of it, however, I'm wonderingadoes the...
Market Intelligence Center  Aug 22  Comment 
Option-trade picking algorithms patented by found a trading opportunity with First Trust NYSE Arca Biotech Index (FBT) that should provide a 3.48% return in just 92 days. Buy one Nov. '14 call at the $88.00 level for...
FierceBiotech  Aug 22  Comment 
Israeli biotech NeuroDerm has secured a $16 million investment to support its work on a wearable treatment for Parkinson's disease, working through a mid-stage study on its lead candidate for the neurodegenerative ailment.
The Australian  Aug 22  Comment 
ESRA Ogru, the high-profile ex-CEO of biotech Phosphagenics, has pleaded guilty to misappropriating $6.1m of company money.


Related Articles


Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors

Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share


  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009

M&A Biotechnology

Monoclonal Antibody Market 2009

Vaccine Market 2009

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs)

M&A Review: Pharmaceutical & Biotechnology Industry

Global Vaccine Market Review 2008 (World Top Ten Vaccines)

Ipilimumab (BMS) Review: A Cancer Breakthrough?

Denosumab (Prolia, Amgen) FDA Review & Approval

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki